Soloway Thomas P 4
4 · Satsuma Pharmaceuticals, Inc. · Filed Dec 7, 2020
Insider Transaction Report
Form 4
Soloway Thomas P
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-12-03+20,000→ 20,000 totalExercise: $4.60Exp: 2030-12-03→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The option shall vest in full and become exercisable on the day immediately preceding the 2022 Annual Meeting.